Not sure why you are tagging them instead of just the links to their post but a quick research of IHL show the company are in clinical trials for 6 products which all have a big market whereas wheezo is already in commercialisation for a product which has a small niche market as evidence by the commercialsation in Australia.
Like I told you $10 per month isn't even that expense in Australia, yet you don't seem to be concern with this massive discrepancy between the 1.2K units sales last year but out of them only 10 subscription for the following year.
- Forums
- ASX - By Stock
- RSH
- Ann: EAS Advisors LLC appointed to assist with US growth
Ann: EAS Advisors LLC appointed to assist with US growth, page-10
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RSH (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.95M |
Open | High | Low | Value | Volume |
3.0¢ | 3.0¢ | 2.7¢ | $9.038K | 330.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 539500 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 318282 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 539500 | 0.026 |
3 | 800000 | 0.025 |
1 | 130000 | 0.022 |
1 | 3245 | 0.021 |
2 | 1200000 | 0.020 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 318282 | 1 |
0.031 | 4450000 | 2 |
0.032 | 615000 | 5 |
0.034 | 400000 | 1 |
0.035 | 199456 | 1 |
Last trade - 12.16pm 05/08/2024 (20 minute delay) ? |
Featured News
RSH (ASX) Chart |